Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2011

View Archived Issues

Abciximab combined with heparin may be useful to treat stroke

Omeros identifies compounds that interact with GPCRs linked to metabolic and psychotic disorders

Solvay's SLV-338 alleviates symptoms of pulmonary hypertension in vivo

Novel MEK 1 inhibitors synthesized at Novartis

Athersys reports interim data from ongoing phase I MultiStem study

Preliminary phase III data presented at ASCO on bosutinib versus imatinib in Ph+ CML

Proactivator polypeptide described as new biomarker in prostate cancer

New data disclosed on duloxetine in chronic depression, MDD and GAD

Gilead presents new voltage-gated Na(V)1.5 sodium channel blockers

Novadex Pharmaceuticals discloses novel renin inhibitors

Grindeks claims new cognition-enhancing piracetam derivative enantiomer

New ghrelin receptor antagonists and/or inverse agonists synthesized

Novel 9-aminoacridine derivatives for cancer presented

Immunovaccine's phase I DPX-0907 trial meets primary objective

Asimadoline receives FDA fast track status for diarrhea-predominant irritable bowel syndrome

Ono and Daninippon Sumitomo to codevelop limaprost for carpal tunnel syndrome

Recruitment begins in phase Ib Ampion trial in osteoarthritis of the knee

Phase III data reported on CVT-E002 for acute respiratory illness in chronic lymphocytic leukemia

Aastrom's RESTORE-CLI trial meets primary safety and efficacy endpoints

Week 56 data consistent with earlier results in phase III lomitapide trial in HoFH

Kyowa Hakko Kirin and Valeant terminate North American licensing agreement for KW-6002

Bristol-Myers Squibb and Roche enter agreement to evaluate ipilimumab/vemurafenib combination

AVEO and Centocor Ortho Biotech enter license agreement for antibodies targeting MSP receptor

Lpath reports encouraging preclinical data on Lpathomab

GSK and Theravance provide results from two pivotal phase III Relovair trials in COPD

FDA finds no evidence of increased risk of cancer in safety review of ARBs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...